At the end of September, the European Union officially launched the new European partnership ‘One Health Antimicrobial Resistance’ (OHAMR): €253 million for research and innovation against antimicrobial resistance (AMR). Co-funded by Horizon Europe to the tune of €75 million, this ambitious ten-year programme tackles the urgent global health threat posed by antimicrobial resistance.
- Visit https://ohamr.eu
Coordinated by the Swedish Research Council, OHAMR brings together 53 organisations from 30 countries under a ‘One Health’ approach to connect sectors and accelerate the implementation of solutions to reduce antimicrobial use and resistance.
Activities planned under the partnership include:
- Joint transnational calls for collaborative research and innovation projects;
- Strengthening research capacities in participating countries;
- Promoting the implementation and translation of knowledge into policy;
- Supporting access to and better use of AMR data;
- Strengthening impact through coordination and harmonisation of national and European efforts.
This partnership will contribute in particular to the implementation of the Strategy for European Life Sciences by promoting a ‘One Health’ approach, which recognises the interdependence between human, animal and environmental health, a key principle set out in the strategy.
- See the news “Successful kick-off in Brussels for the EUP OHAMR“